tiprankstipranks
Trending News
More News >
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market
Advertisement

ARS Pharmaceuticals (SPRY) Revenue

Compare
518 Followers

ARS Pharmaceuticals Revenue

ARS Pharmaceuticals had a revenue of 15.72M in the quarter ending Jun 30, 2025, with 97.13%. This bring the company's revenue in the last twelve months to 112.34M, Decreased 15.67%. In the fiscal year ending Dec 31, 2024, ARS Pharmaceuticals had annual revenue of 89.15M with 297063.33% growth.
Revenue (ttm)
112.34M
Revenue Growth
22367.80%
P/S Ratio
10.41
Revenue/Employee
$575,155
Employees
155
Market Cap
$927.98M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
89.15M89.12M+297,173.24%
Dec 31, 2023
30.00K-1.29M+2.28%
Dec 31, 2022
1.32M-4.19M+23.90%
Dec 31, 2021
5.51M-12.33M+30.87%
Dec 31, 2020
17.84M-1,783,500,000.00%
Dec 31, 2019
Dec 31, 2018
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis